Related Experiment Video
Updated: Mar 24, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Protein Kinase Cι Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma
Syed A Ali1, Verline Justilien1, Lee Jamieson1
1Department of Cancer Biology, Mayo Clinic Cancer Center, Jacksonville, FL 32224, USA.
Abstract:
We report that the protein kinase Cι (PKCι) oncogene controls expression of NOTCH3, a key driver of stemness, in KRAS-mediated lung adenocarcinoma (LADC). PKCι activates NOTCH3 expression by phosphorylating the ELF3 transcription factor and driving ELF3 occupancy on the NOTCH3 promoter. PKCι-ELF3-NOTCH3 signaling controls the tumor-initiating cell phenotype by regulating asymmetric cell division, a process necessary for tumor initiation and maintenance. Primary LADC tumors exhibit PKCι-ELF3-NOTCH3 signaling, and combined pharmacologic blockade of PKCι and NOTCH synergistically inhibits tumorigenic behavior in vitro and LADC growth in vivo demonstrating the therapeutic potential of PKCι-ELF3-NOTCH3 signal inhibition to more effectively treat KRAS LADC.
Insights
Protein kinase Cι (PKCι) drives lung adenocarcinoma (LADC) by activating NOTCH3 expression via the ELF3 transcription factor. Targeting this PKCι-ELF3-NOTCH3 pathway shows promise for treating KRAS-mutated LADC.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- KRAS-mediated lung adenocarcinoma (LADC) is a significant clinical challenge.
- Tumor stemness and asymmetric cell division are critical for LADC initiation and maintenance.
- The role of protein kinase Cι (PKCι) in LADC stemness is not fully understood.
Purpose of the Study:
- To elucidate the molecular mechanism by which PKCι regulates stemness in LADC.
- To investigate the role of the NOTCH3 pathway in PKCι-driven LADC.
- To evaluate the therapeutic potential of targeting the PKCι-ELF3-NOTCH3 signaling axis.
Main Methods:
- Investigated the interaction between PKCι, ELF3, and NOTCH3 in LADC cells.
- Assessed ELF3 occupancy on the NOTCH3 promoter using chromatin immunoprecipitation assays.
- Examined the effect of PKCι and NOTCH inhibition on asymmetric cell division and tumor growth in vitro and in vivo.
Main Results:
- PKCι oncogene controls NOTCH3 expression, a key driver of stemness in KRAS-mutated LADC.
- PKCι phosphorylates ELF3, enhancing its binding to the NOTCH3 promoter, thereby activating NOTCH3 expression.
- PKCι-ELF3-NOTCH3 signaling regulates asymmetric cell division, crucial for tumor initiation and maintenance.
- Combined blockade of PKCι and NOTCH synergistically inhibited LADC cell tumorigenicity and tumor growth.
Conclusions:
- The PKCι-ELF3-NOTCH3 signaling pathway is a critical regulator of stemness and tumorigenesis in KRAS-mutated LADC.
- Targeting this pathway offers a promising therapeutic strategy for KRAS LADC.
- Pharmacologic inhibition of PKCι and NOTCH demonstrates significant therapeutic potential.
More Related Videos
Related Concept Videos
The Ras Gene
Ras is a...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation

